Preclinical Characterization of a Novel Anti-Cancer PD-L1 Inhibitor RPH-120

Andrey Kulikov, Elena Shipaeva, Anastasia Dmitrieva, Vera Batrak, Georgy Shipunov, Colin Guy, Jill Smith, Ran Zhang, Michael Zhang, Jeff Duan, Anton Chestukhin, Sergei Barbashov, Mikhail Samsonov, Yan Lavrovsky

Open source

DOI: 10.3389/fphar.2021.723038
Published: 2021-08-11
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2021.723038,
  title = {Preclinical Characterization of a Novel Anti-Cancer PD-L1 Inhibitor RPH-120},
  author = {Andrey Kulikov and Elena Shipaeva and Anastasia Dmitrieva and Vera Batrak and Georgy Shipunov and Colin Guy and Jill Smith and Ran Zhang and Michael Zhang and Jeff Duan and Anton Chestukhin and Sergei Barbashov and Mikhail Samsonov and Yan Lavrovsky},
  year = {2021},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2021.723038},
  url = {https://doi.org/10.3389/fphar.2021.723038}
}

RIS

TY  - JOUR
TI  - Preclinical Characterization of a Novel Anti-Cancer PD-L1 Inhibitor RPH-120
AU  - Andrey Kulikov
AU  - Elena Shipaeva
AU  - Anastasia Dmitrieva
AU  - Vera Batrak
AU  - Georgy Shipunov
AU  - Colin Guy
AU  - Jill Smith
AU  - Ran Zhang
AU  - Michael Zhang
AU  - Jeff Duan
AU  - Anton Chestukhin
AU  - Sergei Barbashov
AU  - Mikhail Samsonov
AU  - Yan Lavrovsky
PY  - 2021
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2021.723038
UR  - https://doi.org/10.3389/fphar.2021.723038
ER  -

APA

Kulikov, A., Shipaeva, E., Dmitrieva, A., Batrak, V., Shipunov, G., Guy, C., Smith, J., Zhang, R., Zhang, M., Duan, J., Chestukhin, A., Barbashov, S., Samsonov, M., & Lavrovsky, Y. (2021). Preclinical Characterization of a Novel Anti-Cancer PD-L1 Inhibitor RPH-120. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.723038

Source records

crossref · retrieved 2026-09-26T08:11:42.632Z